Color Vision Screening

The Rabin Cone Contrast Test detects

changes associated with eye and Neurological diseases

and reducing the overall cost of healthcare.

Further aiding in eyesight preservation,

Sensitive enough to detect the severity of cone deficiency

Can determine hereditary and acquired color deficiency in a single test

Used to detect and monitor acquired color deficiency in eye disease and poor retinal health

Custom Calibration

Calibrated for color and contrast

Detects sub-standard monitors and end-of-life color meters

Scheduled in-field calibration adapts to clinic or research

Ensures validity and repeatability of results

Patient Benefits

Identification of patients at-risk for developing disease

Earlier recognition and intervention of disease

Rapid detection of disease progression

Evaluation of treatment efficacy

Improved Quality of Care

Financial Benefits

Increases Medicare billings for 92283

Extended Color Vision Exam

Drives Medicare billings of structural

diagnostic equipment

Increases clinic economic throughput

by identifying patients most in need of care

Increased Per-Patient Revenue